0001365618-14-000006.txt : 20141021 0001365618-14-000006.hdr.sgml : 20141021 20141021190224 ACCESSION NUMBER: 0001365618-14-000006 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141016 FILED AS OF DATE: 20141021 DATE AS OF CHANGE: 20141021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hove Anders D CENTRAL INDEX KEY: 0001365618 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 141166548 MAIL ADDRESS: STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508 CITY: NEW YORK STATE: NY ZIP: 10112 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2014-10-16 2014-10-20 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001365618 Hove Anders D C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 1 0 0 0 2.00% Convertible Senior Notes due 2021 31.05 2014-10-16 4 A 0 8000000.00 8000000.00 A 2021-07-15 2021-10-15 Common Stock 257648 8000000.00 I By Funds and LLC's The Form 4 filed on October 20, 2014 contained the following errors: a typographical error in Table II, Box 1 changing Debentures to Senior Notes; a typographical error in Table II, Box 2 changing the conversion price to the actual conversion price of $31.05; a typographical error in Table II, Box 6 correcting the exercisable date to July 15, 2021; and a typographical error in Table II, Box 7 increasing the Number of Shares to 257,648. Consists of a convertible promissory note in the amount of $2,029,000.00 held by Venrock Healthcare Capital Partners, L.P. ("VHCP"), a convertible promissory note in the amount of $371,000.00 held by VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), a convertible promissory note in the amount of $4,709,000.00 held by Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and a convertible promissory note in the amount of $891,000.00 held by VHCP Co-Investment Holdings II, LLC ("VHCP Co-Invest II"). VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. VHCP Management II, LLC ("VHCP Management II") is the general partner of VHCP II and the manager of VHCP Co-Invest II and may be deemed to beneficially own these shares. Dr. Hove is a managing member of VHCP Management and VHCP Management II and may be deemed to beneficially own these shares. Dr. Hove, VHCP Management and VHCP Management II expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. /s/ Anders D. Hove 2014-10-21